Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants..
Clinical trial NCT07408908 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07408908
- Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-06
- Primary completion
- 2027-03-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.